ICD-10-CM Billable Code

M61.142

Myositis ossificans progressiva, left hand

Clinical Classification Guidelines

Medical Intelligence & Overview

Myositis ossificans progressiva, also known as progressive heterotopic ossification, is a rare condition characterized by the abnormal formation of bone tissue inside muscles, tendons, and other soft tissues. When occurring in the left hand, it can significantly impact mobility and function, leading to pain and stiffness. Diagnosis of this condition, coded as M61.142 in the ICD-10 system, is essential for proper management and treatment planning.

Causes & Symptoms

Clinical Causes: Previous trauma or injury to the hand or surrounding tissues Genetic factors, particularly in cases associated with rare inherited disorders Repeated or chronic inflammation due to infections or other inflammatory conditions Certain neurological conditions that increase the risk of abnormal bone formation Exposure to radiation or certain medications that may stimulate ossification Unknown causes in some cases, making diagnosis more challenging

Key Symptoms: Progressive swelling and firmness in the affected area Development of a palpable, hard mass within soft tissues of the hand Reduced range of motion or stiffness in the fingers and hand Pain or tenderness around the affected tissues Possible deformity or contracture of the hand or fingers over time Limited ability to perform daily tasks due to decreased hand function

Diagnostic & Treatment

Diagnosis Path: Physical examination to assess swelling, mass formation, and range of motion Radiography (X-ray) to visualize abnormal bone growth within soft tissues Magnetic Resonance Imaging (MRI) for detailed images of soft tissue changes Bone scintigraphy, a nuclear imaging technique, to identify active ossification areas Biopsy in uncertain cases to rule out other conditions like tumors or infections

Treatment Protocols: Conservative approaches such as physical therapy to maintain mobility and prevent joint stiffness Medications including nonsteroidal anti-inflammatory drugs (NSAIDs) to reduce inflammation and discomfort Corticosteroid injections to control inflammation in specific cases Surgical intervention, typically reserved for cases where ossified tissue limits function significantly, with procedures aimed at removing abnormal bone formations Monitoring with imaging studies to track disease progression and response to treatment Avoiding trauma or invasive procedures in the affected area to minimize the risk of exacerbating ossification

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is M61.142 a billable ICD-10 code?
Yes, M61.142 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report M61.142?
Clinical documentation must specify the nature of Myositis ossificans progressiva, left hand and any associated comorbidities for accurate reporting.

Cite this Clinical Reference